53439-87-5 Usage
Uses
Used in Pharmaceutical Industry:
2-OXO-2,3-DIHYDRO-1H-BENZOIMIDAZOLE-5-SULFONYL CHLORIDE is used as a reagent in the synthesis of pharmaceuticals for its ability to undergo various chemical transformations, making it a valuable building block for the synthesis of complex molecules.
Used in Agrochemical Industry:
2-OXO-2,3-DIHYDRO-1H-BENZOIMIDAZOLE-5-SULFONYL CHLORIDE is used as a reagent in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Dye Production:
2-OXO-2,3-DIHYDRO-1H-BENZOIMIDAZOLE-5-SULFONYL CHLORIDE is used as an intermediate in the production of dyes, where its chemical properties allow for the creation of a wide range of colorants for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 53439-87-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,4,3 and 9 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 53439-87:
(7*5)+(6*3)+(5*4)+(4*3)+(3*9)+(2*8)+(1*7)=135
135 % 10 = 5
So 53439-87-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H5ClN2O3S/c8-14(12,13)4-1-2-5-6(3-4)10-7(11)9-5/h1-3H,(H2,9,10,11)
53439-87-5Relevant academic research and scientific papers
NOVEL BENZIMIDAZOLE DERIVATIVE AND USE THEREFOR
-
Paragraph 0125; 0126; 0127, (2019/04/26)
To provide a compound that has excellent oral absorbency and can inhibit Prostate Cancer Antigen-1(PCA-1) enzyme activity.SOLUTION: The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. (Ris H,
HEPATITIS B VIRAL ASSEMBLY EFFECTORS
-
Paragraph 00213, (2016/10/31)
Novel assembly effector compounds having a therapeutic effect against hepatitis B viral (HBV) infection are disclosed. Assembly effector molecules described herein can lead to defective viral assembly and also may affect other viral activities associated with chronic HBV infection. Also disclosed is a process to synthesize disclosed compounds, method of treatment of HBV by administration of disclosed compounds, and use of these compounds in the manufacture of medicaments against HBV.
